Biochemistry and Clinical Significance of Lipoprotein (a)

Keys A Aravanis C Blackburn H Probability of middle aged men developing coronary heart disease in five years. Circulation 1972; 45: 815–28.

Miller GJ Miller NE . Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet 1975; i: 16–19.

Whayne TF Alaupovic P Curry MD Plasma apolipoprotein B and VLDL and HDL cholesterol as risk factors in the development of coronary arterial disease in male patients examined by angiography. Atherosclerosis 1981; 39: 411–24.

Heiss G Taylor HA . Proceedings of a Workshop on Apolipoprotein Quantification. Bethesda MD: US Dept of Health and Human Services, Natl. Inst. Health. NIH Publ. 83–1266. 1982; 7–24.

Rhoads GG Dahlen G Berg K Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986; 256: 2540–4.

Kostner GM Avogardo P Cazzolato G Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981; 38: 10–20.

Gaubutz JW Heiderman C Gotto AM Jr Human plasma lipoprotein (a) structural properties. J Biol Chem 1983; 258: (7): 4582–9.

Uterman G Weber W. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Letts 1983; 154 (2): 357–61.

Armstrong VW Walli AK Seidel D . Isolation. characterisation and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein (a). J Lipid Res 1985; 26: 1314–23.

Fless GM Rolih CA Scanu AM . Heterogeneity of human plasma lipoprotein (a). J Biol Chem 1984; 259: 11470–8.

Krempler F Kostner GM Bolzano K Turnover of lipoprotein (a) in man. J Clin Invest 1980; 65 (6): 1483–90.

Krempler F Kostner GM Bolzano K Lipoprotein Lp(a) is not a catabolic product of other apolipoprotein B containing lipoproteins. Biochem Biophys Acta 1979; 575: 63–70.

Bersot TP Innerarity TL Pitos RF Fat feeding in humans induces lipoproteins of density less than 1·006 that are enriched in apolipoprotein (a) and that cause lipid accumulation in macrophages. J Clin Invest 1986; 77: 622–30.

Krempler F Kostner GM Rosher A Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest 1983; 71: 1431–41.

Albers JJ Cazbano VG Warnick GR Lp(a) lipoprotein-relationship to linking para-β-lipoprotein, hyperlipoproteinaemia and apolipoprotein B. Metabolism. 1975; 24 (9): 1047–54.

Vessby G Kostner GM Liknell H Diverging effects of cholestyramine on lipoprotein and lipoprotein Lp(a)– A dose-response study of the effects of cholestyramine in hypercholesterolaemia. Atherosclerosis 1982; 44: 61–71.

Albers JJ Adolphson JL Hazzard WR . Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 1977; 18: 331–8.

Murai A Miyahara T Fujimoto N Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986; 59: 199–204.

Guyton JR Dahlen GH Patsch W Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Atherosclerosis 1985; 5 (3): 265–72.

Berg K . A new serum type system in man the Lp system. Acta Pathol Microbiol Scand 1963; 59: 369–82.

Utermann G Manzel HJ Kraft HG Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80 (2): 458–65.

Jurgens G. Cryoscopic behaviour of isolated lipoprotein(a) and possible consequences for its use as a standard. Clin Chem 1983; 29 (10): 1856.

Wieland H Seidel D . Improved assessment of plasma lipoprotein patterns: IV simple preparation of a lypophilised control serum containing intact human plasma lipoproteins. Clin Chem 1982; 28: 1335–7.

Dahlen G Ericson C Furberg C Studies on an extra pre-beta lipoprotein fraction. Acta Med Scand 531 (Suppl 1972): 1–28.

Berg K Dahlen G Frick MH . Lp(a) lipoprotein and pre-beta₁-lipoprotein in patients with coronary heart disease. Clin Genet 1974; 6: 230–5.

Dahlen G Berg K Gillnas T Lp(a) lipoprotein/pre-beta₁ lipoprotein in Swedish middle aged males and in patients with coronary heart disease. Clin Genet 1975; 7: 334–41.

Berg K Dahlen G Borresen AL . Lp(a) phenotypes other lipoprotein parameters and family history of heart disease in middle-aged males. Clin Genet 1979; 16: 347–52.

Frick MH Dahlen G Berg K Serum lipids in angiographically assessed coronary atherosclerosis. Chest 1978; 73: 62–5.

Berg K. Inherited lipoprotein variation and atherosclerotic disease. In: Scanu AM Wissler RW Getz GS (eds). The Biochemistry of Atherosclerosis. New York: Marcel Dekker Inc., 1979.

Kostner GM . Apolipoproteins and lipoproteins of human plasma: Significance in health and in disease, In: Paoletti R Kritchersky D (Eds). Advances in Lipid Research. Orlando: Academic Press Inc. 1983; 20: 1–1.

Kostner GM Avogaro P Cozzolato G Lipoprotein Lp(a) and the risk of myocardial infarction. Atherosclerosis 1981; 38: 51–61.

Koltringer P Jurgens G . A dominant role of lipoprotein(a) in the investigation and evaluation of parameters including the development of cervical atherosclerosis. Atherosclerosis 1985; 58: 187–98.

Walton KW Hitchens J Magnani HN A study of methods of identification and extraction of Lp(a) lipoprotein and its significance in health, hyperlipidaemia and atherosclerosis. Atherosclerosis 1974; 20: 323–46.

Armstrong VW Cremer P Eberle E The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986; 62: 249–57.

Brown MS Goldstein JL . Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 1983; 52: 223–61.

Ehaholm C Garott H Renkonen O Protein and carbohydrate composition of Lp(a) lipoprotein from human plasma. Biochemistry 1972; 11: 3229–32.

Jurgens G. In vitro studies on the aggregation of isolated lipoprotein (a) upon addition of lysolethicin. Artery 1983; 11 (6): 432–49.

Eaton DL Fless GM Kohn WJ Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 1987; 84: 3224–8.

McLean JW Tomlinson JE Krang W CDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987; 330: 132–7.

Albers JJ Hazzard WR . Immunochemical quantification of human plasma Lp(a) lipoproteins. Lipids 1974; 9: 15–26.

Kostner G Kein G Krempler F. Is serum Lp(a) concentration be lowered by drugs and/or diet? In: Carlson LA Olsson AG (eds). Treatment of Hyperlipidaemia. New York: Raven Press, 1984; 151.

Gurka A Hoeg J Kostner G Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. Atherosclerosis 1985; 57: 293–301.

Albers JJ Taggart HM Applebaum-Bowden D Reduction of the lecithin: cholesterol acyltransferase, apolipoprotein D and Lp(a) with the anabolic steroid stanzolol. Biochem Biophys Acta 1984; 795: 293–300.

Rhoads GG Morton NE Gulbrandsen CL Sinking pre-beta lipoprotein and coronary heart disease in Japanese-American men in Hawaii. Am J Epidemiol 1978; 108 (5): 250–6.